Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19.
N Engl J Med. 2021 Oct 7;385(15):1382-1392. doi: 10.1056/NEJMoa2102685. Epub 2021 Jul 14.
N Engl J Med. 2021.
PMID: 34260849
Free PMC article.
Clinical Trial.